Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Dementia01:30

Dementia

110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
110
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

172
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introducing the SAGE study: a multimodal protocol for testing a GABAergic mechanism of age-related episodic memory impairment across the sexes.

BMJ neurology open·2026
Same author

Context Memory Discrimination and Recognition in Humans: Development of a Novel Cognitive Task.

JMIR formative research·2026
Same author

In Response to Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease.

The Laryngoscope·2026
Same author

Shorter Wound-healing Times Associated With Select Perioperative Medical Therapies in Hidradenitis Suppurativa Surgery, and a Limited Clinical Role of Intraoperative Cultures: A 194-Case Retrospective Review.

Annals of plastic surgery·2026
Same author

A plasma protein signature for cerebral amyloid angiopathy.

Acta neuropathologica·2026
Same author

Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease.

The Laryngoscope·2026

Related Experiment Video

Updated: Jun 19, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

Alzheimer's disease detection using data fusion with a deep supervised encoder.

Minh Trinh1, Ryan Shahbaba2, Craig Stark3,4

  • 1Department of Computer Science, University of California, Los Angeles, Los Angeles, CA, United States.

Frontiers in Dementia
|July 26, 2024
PubMed
Summary

This study enhances Alzheimer's disease diagnosis by fusing multiple data types. A new supervised encoder method with intermediate data fusion significantly improves computational diagnostic accuracy.

Keywords:
Alzheimer’s biomarkersAlzheimer’s diseasedata integrationdiagnosis predictiondimensionality reductionmultimodal fusionmultiview data integration

More Related Videos

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
03:31

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

Published on: December 15, 2023

515
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

124

Related Experiment Videos

Last Updated: Jun 19, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
03:31

Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

Published on: December 15, 2023

515
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

124

Area of Science:

  • Computational neuroscience
  • Medical informatics
  • Machine learning

Background:

  • Alzheimer's disease (AD) diagnosis requires improved accuracy and early detection methods.
  • Current computational diagnosis often relies on single data modalities, potentially missing crucial information.
  • Integrating diverse data sources (multi-modal data) may offer a more comprehensive patient profile for diagnosis.

Purpose of the Study:

  • To develop an optimal data analysis strategy for enhancing computational diagnosis of Alzheimer's disease.
  • To investigate the impact of data fusion and dimensionality reduction techniques on diagnostic accuracy.
  • To compare various fusion strategies (simple, early, intermediate) and dimensionality reduction methods.

Main Methods:

  • A comprehensive comparison of over 80 statistical machine learning methods was conducted.
  • Explored three data fusion strategies: simple concatenation, early fusion (concatenate then reduce dimensions), and intermediate fusion (reduce dimensions then concatenate).
  • Evaluated common dimensionality reduction techniques (PCA, AE, LASSO) and a novel supervised encoder (SE).

Main Results:

  • The supervised encoder (SE) demonstrated substantial improvements in prediction accuracy compared to PCA, AE, and LASSO.
  • Intermediate data fusion, when combined with SE, yielded the highest accuracy for multiclass diagnosis prediction.
  • Multi-modal data integration, coupled with effective dimensionality reduction, enhances computational diagnostic capabilities.

Conclusions:

  • Optimal data fusion and dimensionality reduction strategies are crucial for accurate computational diagnosis of Alzheimer's disease.
  • The supervised encoder (SE) shows significant promise as a dimensionality reduction technique for multi-modal AD data.
  • This research provides a framework for developing more effective AI-driven diagnostic tools for neurodegenerative diseases.